Biocompatible Matrix Barrier for Implantable Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The placement of metal or polymeric medical devices in the body often results in complications such as increased infection risk, foreign body response, and inflammation due to the introduction of a non-biocompatible material, particularly in devices with subcutaneous elements like tunneled catheters.
Innovation Solution
A biocompatible polymeric controlled release matrix barrier structure comprising compliant or elastomeric polymers and bioactive agents is applied to implantable medical devices, which can conform to the device surface without adhesives, providing a barrier against infection and delivering bioactive agents to prevent complications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If metal or polymeric medical devices are placed in the body, then medical treatment is enabled, but infection risk and foreign body response increase
Solution Approach 1:
The patent applies an intermediary substance (antimicrobial coating or barrier layer) between the medical device and the body tissue to prevent direct interaction that causes infection and foreign body response. This mediator layer allows the device to function while blocking harmful biological reactions.
Solution Approach 2:
The patent uses composite material structures combining biocompatible polymers with antimicrobial agents or surface-modified layers. These composite structures provide both the mechanical functionality of the medical device and the biological compatibility needed to reduce infection risk and inflammation.
2Reliability
If metal or polymeric medical devices are placed in the body, then medical intervention is achieved, but inflammation and fibrous encapsulation occur
Solution Approach 1:
The patent introduces intermediary substances such as anti-inflammatory coatings or biocompatible surface layers that mediate between the device and host tissue, preventing direct provocation of inflammatory responses while maintaining device functionality.
Solution Approach 2:
The patent modifies surface parameters of the medical device including surface energy, roughness, and chemical composition to reduce protein adsorption and cellular adhesion that lead to inflammation and fibrous encapsulation, while preserving the bulk mechanical properties needed for medical intervention.
3Object-affected harmful factors
If a barrier structure is applied to reduce infection risk, then biocompatibility improves, but device complexity increases
Solution Approach 1:
The patent employs thin film coatings and flexible barrier layers that can be applied directly to the device surface during manufacturing. These thin films provide infection protection and biocompatibility without significantly increasing device complexity or size.
Solution Approach 2:
The patent combines the barrier function with the device manufacturing process itself, integrating antimicrobial coatings or biocompatible layers into the device structure during production rather than as separate added components, thereby minimizing complexity increases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The matrix barrier structure effectively reduces infection risk and inflammation by creating a biocompatible interface with the body, allowing for controlled release of bioactive agents to prevent contamination and promote healing, while being easily applied post-manufacturing and adaptable to various device configurations.
Implementation Method 1
the compliant film conforms to the surface of the implantable medical device
Implementation Method 2
the compliant film conforms to and adheres to the surface of the implantable medical device
Implementation Method 3
the step of applying the controlled release matrix barrier structure comprises elastic deformation of the collar by application of a stress on the collar; placement of the collar around the implantable medical device; and release of the stress on the collar, wherein the collar substantially returns to its initial shape upon release of the stress
Implementation Method 4
biocompatible polymeric controlled release matrix barrier structure comprising one or more biocompatible polymers and one or more bioactive agents
Data Source
AI summary
A biocompatible polymeric controlled release matrix barrier structure for delivery of one or more bioactive agents from an implantable medical device is described. In an embodiment, a biocompatible polymeric controlled release matrix barrier structure is included. The biocompatible polymeric controlled release matrix can include a body structure formed of a compliant material comprising one or more compliant biocompatible polymers and one or more bioactive agents. The body structure can define a central aperture through which a subcutaneous element of an implantable medical device passes. Other embodiments are included herein.